Chronic Kidney Disease Trial

Active-controlled study to assess the efficacy, safety, and tolerability of investigational drug Baxdrostat in combination with Dapagliflozin compared with Dapagliflozin alone on chronic kidney disease (CKD) progression in participants with CKD and high blood pressure.

Are you interested in participating in this clinical study?

Active-controlled study to assess the efficacy, safety, and tolerability of investigational drug Baxdrostat in combination with Dapagliflozin compared with Dapagliflozin alone on chronic kidney disease (CKD) progression in participants with CKD and high blood pressure.

Inclusion criteria

      • Male or females non-childbearing potential must be > 18 years of age
      • EGFR ≥ 30 and < 90 ml/min/1.73 m2
      • Participants with history of HTN and a SBP ≥ 130 mmhg and ≥ 120mmhg
      • Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form and in this protocol

For more information:

Call us 786-772-0510

Call us:
786-772-0510
Location:
Hialeah, FL
    • VA: Greetings, I am Indago's Virtual Assistant. Kindly note that the information I provide may not be guaranteed for accuracy and my voice is AI generated. How may I help you? También hablo español y otros idiomas

    Virtual Assistant is thinking ...
  • Virtual Assistant
    Close
    Skip to content